iCanQuit Smoking Cessation Among Hispanic Adults

NCT06811038 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 854

Last updated 2026-05-11

No results posted yet for this study

Summary

This phase III trial compares a smartphone application with or without nicotine replacement therapy in improving smoking cessation among Hispanic adults who would like to quit smoking. The iCanQuit smartphone application focuses on skills for managing urges, motivation, and relapse prevention with personalized quit plans. Nicotine replacement therapy works by giving small, steady doses of nicotine to help stop cravings and relieve symptoms that occur when a person is trying to quit smoking without any of the other harmful chemicals found in tobacco products.

Conditions

  • Cigarette Smoking-Related Carcinoma

Interventions

DEVICE

iCanQuit Smartphone App Smoking Cessation Program

Receive access to iCanQuit app, with daily push notifications

DRUG

Nicotine Gum

Receive nicotine replacement therapy gum

DRUG

Nicotine Patch

Receive nicotine replacement therapy patch(es)

DRUG

Nicotine Lozenge

Receive nicotine replacement therapy lozenge(s)

OTHER

Survey Administration

Ancillary studies

OTHER

Interview

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH
  • Fred Hutchinson Cancer Center

    lead OTHER

Principal Investigators

  • Jonathan Bricker, PhD · Fred Hutch/University of Washington Cancer Consortium

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-06-01
Primary Completion
2029-07-01
Completion
2030-07-01
FDA Drug
Yes
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06811038 on ClinicalTrials.gov